Document:

FIRST ALLONGE TO 

PROMISSORY NOTE (COMMERCIAL –
REVOLVING DRAW)

 

This FIRST ALLONGE TO PROMISSORY NOTE (COMMERCIAL
– REVOLVING DRAW) (“Allonge”) is effective December 21, 2012 (the “Effective Date”) by and between
CARDINAL BANK (the “Bank”) and WIDEPOINT CORPORATION, WIDEPOINT SOLUTIONS CORPORATION, WIDEPOINT IL, INC., WIDEPOINT
NBIL, INC., ADVANCED RESPONSE CONCEPTS CORPORATION, PROTEXX TECHNOLOGY CORPORATION, OPERATIONAL RESEARCH CONSULTANTS, INC., ISYS,
LLC and WIDEPOINT OHIO REAL ESTATE CORPORATION (jointly, severally and collectively, the “Borrower”).

 

W I T N E S S E T H:

 

WHEREAS, on or about December 30, 2011,
Bank made a revolving loan to Borrower in the original aggregate maximum principal amount of EIGHT MILLION AND NO/100 DOLLARS ($8,000,000.00)
(collectively, the “Loan”); and

 

WHEREAS, the Loan is evidenced by,
among other things, Borrower’s Promissory Note (Commercial – Revolving Draw) in the original maximum principal amount
up to $8,000,000.00 dated December 30, 2012 (the “Note”); and

 

WHEREAS, the parties now desire to enter
into this Allonge to modify certain terms of the Note.

 

NOW, THEREFORE, for and in consideration
of the foregoing recitals and the mutual covenants and conditions contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.     
The first paragraph in Section 7 of the Note (titled “Payment”) is hereby deleted in its entirety and replaced
by the following:

 

Payment. I agree to pay all accrued interest on the
balance outstanding from time to time in regular payments beginning January 30, 2012, then on the same day of each month thereafter.
Any payment scheduled for a date falling beyond the last day of the month will be due on the last day. A final payment of the entire
unpaid outstanding balance of Principal and interest will be due June 30, 2014.

 

2.     
No Other Modification. Except as expressly modified hereby, all of the terms and conditions of the Note remain in
full force and effect and are renewed, extended and brought forward and not terminated hereby. The Borrower hereby represents and
warrants that as of the date hereof, the Note is in full force and effect, valid, binding and enforceable in accordance with its
terms, without offset, reduction or credit, and that there exists no default thereunder.

 

    	1

    	 

    

 

3.     
 Fees and Costs. The modification as set forth in this Allonge are subject to each of the following conditions:

 

		(a)	Borrower shall have paid to the Bank all the following:

 

		(i)	The Bank’s attorney’s fees incurred in connection with the preparation of this Allonge and the ancillary loan documents
associated therewith;

 

		(ii)	Any and all filing fees, title insurance, release fees or other costs, charges or expenses incurred in connection with the
consummation of the agreements set forth herein; and

 

		(iii)	An extension fee of $8,000.00.

 

		(iv)	All of the foregoing shall be paid without demand and without offset or reduction and may be directly debited from Borrower’s
operating account at the Bank. The failure to fully and timely pay the foregoing shall constitute an Event of Default under the
loan documents.

 

4.     
This Allonge may be executed in counterparts which, when taken together, shall constitute one and the same instrument.

 

 

 

[Signatures appear on following pages]

 

    	2

    	 

    

IN WITNESS WHEREOF, this First Allonge is executed under seal as of the day and year first above written.

 

	 	 	 	BORROWER:
	 	 	 	 
	 	 	 	WIDEPOINT CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	By:	 	[SEAL]
	 	 	 	 	James T. McCubbin, Executive Vice President	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	WIDEPOINT SOLUTIONS CORP.	 
	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	WIDEPOINT IL, INC.
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	WIDEPOINT NBIL, INC.
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	WIDEPOINT OHIO REAL ESTATE CORP.
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 

 

 

    	3

    	 

    

 

	 	 	 	OPERATIONAL RESEARCH CONSULTANTS, INC.
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	ISYS, LLC
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	ADVANCED RESPONSE CONCEPTS CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	PROTEXX ACQUISITION CORPORATION
	 	 	 	 
	 	 	 	 
	 	 	 	By: 	 	[SEAL]
	 	 	 	 	James T. McCubbin, Vice President

 

  

STATE OF ______________:

COUNTY OF ___________:

 

I, the undersigned Notary Public of and
for the jurisdiction aforesaid, do certify that James T. McCubbin, Executive Vice President of WidePoint Corporation and Vice President
of WidePoint Solutions Corp., Widepoint IL, Inc., Widepoint NBIL, Inc., Widepoint Ohio Real Estate Corp., Operational Research
Consultants, Inc., iSYS, LLC, Advanced Response Concepts Corporation and Protexx Acquisition Corporation, personally known to me
or satisfactorily proven, whose name is signed to the foregoing Allonge has acknowledged the same me in my jurisdiction aforesaid.

 

Given under my hand this __________ day
of ________________, 2012.

 

____________________________________

Notary
Public

My Commission Expires:

___________________

 

    	4Exhibit 10.1

 

SUPERIOR COURT OF THE STATE OF CALIFORNIA

FOR THE COUNTY OF LOS ANGELES

CENTRAL DISTRICT

 

	
        IRONRIDGE GLOBAL IV, LTD.,

         

        Plaintiff

         

        v.

         

        ADVAXIS, INC.,

         

        Defendant
	
        Case No: BC497504

         

        Assigned for All Purposes to: Hon. Daniel Buckley

         

        ORDER FOR 

        APPROVAL OF STIPULATION FOR SETTLEMENT OF CLAIMS

         

        Date: December 20, 2012 Time: 8:30 am

        Dept: 35

        Trial Date: None Set 

 

The Joint Ex Parte
Application for Court Approval of Stipulated Settlement (“Application”), filed by Plaintiff Ironridge Global
IV, Ltd. (“Plaintiff’) and Advaxis, Inc. (“Defendant”), came on for hearing on December 20,
2012 at 8:30 am in Department 35 of the above-entitled court, the Honorable Daniel Buckley, Judge presiding.

 

The Court having considered
the Application and supporting papers, the oral arguments of counsel, having been presented with a Stipulation for Settlement of
Claims (“Stipulation”), and good cause appearing therefor,

 

IT IS HEREBY ORDERED
AS FOLLOWS:

 

1.    The Stipulation,
attached hereto as Exhibit A and incorporated herein by reference, is approved in its entirety;

 

2.    Plaintiff owns
bona fide outstanding claims against Defendant, and the terms and conditions of the issuance and exchange of such claims for free-trading
shares of common stock of Defendant, as set forth in the Stipulation, are approved after a hearing upon the fairness of such terms
and conditions at which Plaintiff, the only person to whom it is proposed to issue securities in such exchange, had the right to
appear;

 

3.    The above-entitled
action is dismissed in its entirety; provided that the Court shall retain jurisdiction to enforce the terms of this Order by a
motion under California Code of Civil Procedure Section 664.6.

 

IT IS SO ORDERED.

 

	DATED: December 20, 2012	/s/ Daniel J. Buckley
	 	Judge of the Superior CourtExhibit 10.2

 

LIBERTAS LAW GROUP

Mark A. Vega (SBN 162621)

mvega@libertaslaw.com

Mona Mahdara Alcala (SBN 270384)

malcala@libertaslaw.com

6427 West Sunset Boulevard

Hollywood, CA 90028

P (323) 306-3870; F (323) 306-3874

 

Attorneys for Plaintiff

IRONRIDGE GLOBAL IV, LTD.

 

C.M. BRAINARD & ASSOCIATES

Christopher M. Brainard (SBN 199444)

christopherbrainard@gmail.com

1715 Via El Prado, Unit 9

Redondo Beach, CA 90277

P (310) 266-4115; F (866) 222-1870

 

Attorneys for Defendant

ADVAXIS, INC.

 

SUPERIOR COURT OF THE STATE OF CALIFORNIA

 

FOR THE COUNTY OF LOS ANGELES

 

CENTRAL DISTRICT

 

 

	
        IRONRIDGE GLOBAL IV, LTD.,

         

        Plaintiff,

         

        v.

         

        ADVAXIS, INC.,

         

        Defendant.
	
        Case No: BC 497504

         

        Assigned for All Purposes to:

        Hon. Daniel Buckley

         

        STIPULATION FOR 

        SETTLEMENT OF CLAIMS

         

        Date: December 20, 2012

        Time: 8:30 a.m.

        Dept: 35

         

        Trial Date: None Set

 

    	 

    	 

    

 

Plaintiff Ironridge
Global IV, Ltd. (“Plaintiff”) and defendant Advaxis, Inc. (“Defendant”), hereby stipulate
to the facts, terms, and conditions contained in the [Proposed] Order Approving Stipulation for Settlement of Claims (“Order”)
submitted herewith and incorporated herein by this reference, and further stipulate and agree as follows:

 

1.    Plaintiff and
Defendant request that this Court enter an order substantially in the form of the concurrently filed proposed Order.

 

2.    Defendant is
a biotechnology company focused on the development of next generation immunotherapies for cancer and other infectious diseases.
Defendant is a public company whose stock is traded under the ticker symbol “ADXS.”

 

3.    Plaintiff owns
bona fide claims (the “Claims”) against Defendant in an aggregate amount of $611,196.29 (the “Claim
Amount”), plus attorneys’ fees. Defendant has not paid the amount due on the Claims. Plaintiff filed the above-captioned
collection action, which the parties now seek to settle by this Stipulation and the proposed Order.

 

4.    Defendant desires
to settle the Claims in exchange for the issuance to Plaintiff of shares of Defendant’s common stock (“Common Stock”).
Plaintiff desires to accept such shares in accordance with the terms of this Stipulation, subject to court approval following a
hearing as envisioned by Section 25017(f)(3) of the California Corporations Code, and Section 3(a)(10) of the federal
Securities Act of 1933, as amended (the “Securities Act”).

 

5.   Plaintiff has
agreed to the proposed settlement terms and conditions, and believes that they are sufficiently fair such that Plaintiff is willing
to enter into this Stipulation. In addition, Defendant’s board of directors has considered the proposed transaction and has
resolved that its terms and conditions are fair to, and in the best interests of, Defendant and its stockholders. Accordingly,
both parties request Court approval of the settlement provided for herein as fair, reasonable and adequate. The parties submit
this Stipulation to the Court on ex parte application, and request that the Court enter an Order approving this Stipulation
following the hearing thereon.

 

6.  It is the intent
and effect of this Stipulation that the Order, when signed, shall end, finally and forever any claim to payment or compensation
of any kind or nature that Plaintiff had, now has, or may assert in the future against Defendant arising out of the Claims. In
this regard, and subject to compliance with the Order, effective upon the execution of the Order, each party hereby releases and
forever discharges the other party, including all of the other party’s officers, directors, members, managers, representatives,
agents and attorneys, from any and all claims, demands, debts, liabilities, obligations, and causes of action, whether known or
unknown, at law or in equity, suspected or unsuspected, fixed or contingent, arising out of, connected with, or incidental to the
Claims. Each party further agrees that with respect to the matters released herein, such party expressly waives any and all rights
and benefits conferred upon it by the provisions of California Civil Code Section 1542 and any similar law of any state or territory
of the United States. California Civil Code Section 1542 provides, in full, as follows: “§1542 General Release—Claim
Extinguished. A general release does not extend to Claims which the creditor does not know or suspect to exist in his or her favor
at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the
debtor.”

 

    	2

    	 

    

 

7.   In full and final
settlement of the Claims, Defendant will issue and deliver to Plaintiff the sum of 45,000,000 shares of Common Stock (the “Initial
Issuance”), subject to the subsequent adjustment, issuances, returns, and ownership limitations set forth below.

 

8.    No later than
the first business day following the date that the Court enters the Order, time being of the essence, Defendant shall take or cause
to be taken all such necessary action including, without limitation, the execution and delivery of such further instruments and
documents, as may be reasonably requested by any party for such purposes or otherwise necessary to complete or perfect the transaction
contemplated hereby, including, but not limited to: (a) deliver a copy of the Order to Defendant’s transfer agent, (b) cause
its legal counsel to issue an opinion to Defendant’s transfer agent, in form and substance acceptable to Plaintiff and such
transfer agent, that the shares of Common Stock to be issued pursuant to the Order (i) are legally issued, fully paid and non-assessable,
(ii) when issued in accordance with the Order will be exempt from the registration requirements under the Securities Act, and (iii)
may be issued without restrictive legend and resold by Plaintiff without restriction; (c) transmit via email, facsimile and overnight
delivery an irrevocable and unconditional instruction to Defendant’s stock transfer agent, in form and substance acceptable
to Plaintiff and such transfer agent, to reserve and issue all shares of Common Stock required by the Order; and (d) issue the
Initial Issuance, as Direct Registration System (DRS) shares to Plaintiff’s balance account with The Depository Trust Company
(DTC) or through the Fast Automated Securities Transfer (FAST) Program of DTC’s Deposit/Withdrawal Agent Commission (DWAC)
system, without any restriction on transfer or resale. The date upon which the Initial Issuance is complete and the shares have
been received into Plaintiff’s account in electronic form and fully cleared for trading shall be referred to as the “Issuance
Date.”

 

9.    From the date
of this Stipulation until that number of consecutive trading days following the Issuance Date required for the aggregate trading
volume of the Common Stock to exceed $6 million (the “Calculation Period”), Plaintiff will retain (a) 1,800,000
shares of Common Stock, plus (b) that number of shares of Common Stock (the “Final Amount”) with an aggregate
value equal to (a) the sum of the Claim Amount plus agent fees of $66,000 and Plaintiff’s reasonable attorney fees and expenses,
(b) divided by 75% of the following: the closing price of the Common Stock on the trading day immediately preceding the date of
entry of the Order, not to exceed the arithmetic average of the individual volume weighted average prices of any five trading days
during the Calculation Period, as reported by the Bloomberg Professional service of Bloomberg LP (“Bloomberg”).

 

10.  At any time
during the Calculation Period the issued shares are less than any reasonably possible Final Amount or a daily VWAP is below 75%
of the closing price on the day before the Issuance Date, Plaintiff may request that Defendant reserve and issue additional shares
of Common Stock (each, an “Additional Issuance”) as soon as possible, and in any event within one trading day,
time being of the essence of any such request, and the Company’s transfer agent, officers, directors and attorneys, including
without limitation Thomas A. Moore and Mark J. Rosenblum shall take all actions necessary to do so. For each day after Plaintiff
requests issuance that shares are not, for any reason, received into Plaintiff’s account in electronic form and fully cleared
for trading, the Calculation Period shall be extended by one trading day.

 

    	3

    	 

    

 

11.  Under no circumstances
shall Defendant issue to Plaintiff at any one time a number of Shares which, when aggregated with all shares of Common Stock then
beneficially owned or controlled by Plaintiff or its affiliates, at such time exceed 9.99% of the total number of shares of Common
Stock then outstanding.

 

12.  At the end of
the Calculation Period, (a) if the sum of the Initial Issuance and any Additional Issuances is less than the Final Amount, Plaintiff
shall issue additional shares of Common Stock to Defendant as soon as possible, up to the Final Amount, and (b) if the sum of the
Initial Issuance and any Additional Issuance is greater than the Final Amount, Plaintiff shall promptly return any remaining shares
to Defendant or its transfer agent for cancellation, (“Final Adjustment”).

 

13.  Defendant hereby
represents, warrants and covenants as follows: (a) there are currently 435,265,112 shares of Common Stock of Defendant issued and
outstanding, and 72,500,000 authorized, unissued and unreserved shares available for reservation and issuance to Plaintiff; (b)
the shares of Common Stock to be issued pursuant to the Order are duly authorized, and when issued will be validly and legally
issued, fully paid and non-assessable, free and clear of all liens, encumbrances and preemptive and similar rights to subscribe
for or purchase securities; (c) the shares to be issued pursuant to the Order (i) are exempt from registration under the Securities
Act, (ii) are issuable without any restrictive legend, and (iii) may be resold by Plaintiff without restriction; (d) Defendant
has reserved from its duly authorized capital stock 27,500,000 shares of Common Stock that could be issued to Plaintiff pursuant
to the terms of the Order if necessary; (e) if at any time it appears reasonably possible that there may be insufficient authorized
or reserved shares to fully comply with the Order, Defendant shall take all action required to immediately reserve additional shares
from authorized shares and, if necessary, promptly take such actions are required to increase its authorized shares so as to ensure
its ability to timely comply with the Order, and may not reserve or issue any shares of Common Stock to any other person unless
and until sufficient shares have been reserved for Plaintiff (except to the extent that a person has the right to purchase shares
of Common Stock on or before the date of this Stipulation); (f) execution of this Stipulation and performance of the Order by Defendant
and Plaintiff will not (i) conflict with, violate, or cause a breach or default under any agreements between Defendant and any
creditor, or any affiliate thereof, including but not limited to those related to the account receivables comprising the Claims,
or (ii) require any waiver, consent, or other action of Defendant or any creditor, or their respective affiliates, that has not
already been obtained in writing; (g) Defendant hereby waives, without limitation, any provision in any agreement related to the
account receivables comprising the Claims requiring payments to be applied in a certain order, manner, or fashion, or providing
for exclusive jurisdiction in any court other than this Court; (h) Defendant has all necessary power and authority to execute,
deliver and perform all of its obligations under this Stipulation; (i) the execution, delivery and performance of this Stipulation
by Defendant has been duly authorized by all requisite action on the part of Defendant, including without limitation express approval
by its board of directors, (j) this Stipulation has been duly executed and delivered by Defendant, and is fully enforceable against
Defendant in accordance with its terms; (k) neither Plaintiff nor any of the creditors from whom Plaintiff acquired the Claims,
nor any of their affiliates, (i) is or was an affiliate of Defendant within the last 90 days or (ii) has or will, directly or indirectly,
provide any consideration to or invest in any manner in Defendant in exchange or consideration for selling or satisfying the Claims
other than pursuant to the Order; (l) neither Defendant nor any of Defendant’s affiliates or agents has or will provide Plaintiff
with any material non-public information regarding Defendant; (m) Plaintiff has no obligation of confidentiality, and may sell
any of its shares of the Company’s common stock issued pursuant to the Order at any time, including without limitation throughout
the Calculation Period; and (n) with respect to this Stipulation and the transactions contemplated hereby (i) Plaintiff is acting
solely in an arm’s length capacity, (ii) Plaintiff does not make or has not made any representations or warranties other
than those specifically set forth herein, (iii) Plaintiff has not and is not acting as a legal, financial, accounting or tax advisor
to Defendant, or agent or fiduciary of Defendant, or in any similar capacity, and (iv) any statement made by Plaintiff or any of
Plaintiff’s representatives, agents or attorneys is not advice or a recommendation to Defendant.

 

    	4

    	 

    

 

14.  Until at least
180 days after the end of the Calculation Period, neither Plaintiff nor any of its affiliates shall (a) hold any short position
in the Common Stock, or (b) engage in or affect, directly or indirectly, any short sale of the Common Stock.

 

15.  For so long
as Plaintiff or any of its affiliates holds any shares of Common Stock, neither Plaintiff nor any of its affiliates shall: (a)
vote any shares of Common Stock owned or controlled by it, exercise any dissenter’s rights, execute or solicit any proxies
or seek to advise or influence any person with respect to any voting securities of Defendant; or (b) engage or participate in any
actions, plans or proposals that relate to or would result in (i) Plaintiff or any of its affiliates acquiring additional securities
of Defendant, alone or together with any other person, which would result in Plaintiff and its affiliates collectively beneficially
owning or controlling, or being deemed to beneficially own or control, more than 9.99% of the total outstanding Common Stock or
other voting securities of Defendant at any one time, (ii) an extraordinary corporate transaction, such as a merger, reorganization
or liquidation, involving Defendant or any of its subsidiaries, (iii) a sale or transfer of a material amount of assets of Defendant
or any of its subsidiaries, (iv) any change in the present board of directors or management of Defendant, including any plans or
proposals to change the number or term of directors or to fill any existing vacancies on the board, (v) any material change in
the present capitalization or dividend policy of Defendant, (vi) any other material change in Defendant’s business or corporate
structure, (vii) changes in Defendant’s charter, bylaws or instruments corresponding thereto or other actions which
may impede the acquisition of control of Defendant by any person, (viii) causing a class of securities of Defendant to be delisted
from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered
national securities association, (ix) causing a class of equity securities of Defendant to become eligible for termination of registration
pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended, or (x) taking any action, intention, plan or arrangement
similar to any of those enumerated above. The provisions of this paragraph may not be modified or waived without further order
of the Court.

 

16.  Defendant shall
indemnify, defend and hold Plaintiff and its affiliates harmless with respect to all claims, actions and proceedings arising out
or related to this Stipulation or the Order, including without limitation, any claim or action brought derivatively or by any one
or more shareholders or creditors of Defendant.

 

17.  The parties
to this Stipulation represent that each of them has been advised as to the terms and legal effect of this Stipulation and the Order
provided for herein, and that the settlement and compromise stated herein is final and conclusive forthwith, subject to the conditions
stated herein, and each attorney represents that his or her client has freely consented to and authorized this Stipulation after
having been so advised.

 

    	5

    	 

    

 

18.  This Stipulation
constitutes Defendant’s answer to the Complaint in this Action. Each party hereto waives a statement of decision, and the
right to appeal from the Order after its entry. Defendant further waives any defense based on the rule against splitting causes
of action. There shall be no third party beneficiaries with respect to this Stipulation or the Order. The prevailing party in any
proceeding required to enforce this Stipulation, the Order, or any judgment or order issued thereon, shall be awarded its reasonable
attorney fees costs and expenses arising out of or relating to such legal proceedings. Except as expressly set forth herein, each
party shall bear its own attorneys’ fees, costs and expenses.

 

19.  Upon entry of
the Order approving this Stipulation, the Action shall be dismissed in its entirety with prejudice, except that the Court shall
retain jurisdiction to enforce the terms of the Stipulation and Order by a motion, application or other proceeding brought by any
party under Section 664.6 of the California Code of Civil Procedure.

 

20.  This Stipulation
may be executed in counterparts and transmitted by facsimile, in portable document format (pdf), or other electronic format, each
of which shall constitute an original and all of which together shall be deemed a single instrument.

 

IT IS SO STIPULATED:

 

	Dated:  December 19, 2012	IRONRIDGE GLOBAL IV, LTD.
	 	 	 
	 	By:	/s/ Peter Cooper
	 	 	Peter Cooper
	 	 	Director
	 	 	 
	Dated:  December 19, 2012	LIBERTAS LAW GROUP
	 	 	 
	 	By:	/s/ Mark A. Vega
	 	 	Mark A. Vega
	 	 	Mona Mahdara Alcala
	 	 	Attorneys for Plaintiff
	 	 	IRONRIDGE GLOBAL IV, LTD.
	 	 	 
	Dated:  December 19, 2012	ADVAXIS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Moore
	 	 	Thomas A. Moore
	 	 	Chief Executive Officer

 

    	6

    	 

    

 

	Dated:  December 19, 2012	C.M. BRAINARD & ASSOCIATES
	 	 	 
	 	By:	/s/ Christopher Brainard
	 	 	Christopher Brainard
	 	 	Attorneys for Defendant
	 	 	ADVAXIS, INC.

 

    	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]